The loratadine syrup market was valued at USD689.7Mn by 2019. The constant rise in the water and air pollution and the rising incidence of anaphylactic shock reactions associated with drug-induced and raw food intake primarily determine the loratadine syrup market growth. Furthermore, the availability of loratadine syrup as over the counter product will accentuate its market growth during the forecast period.

Loratadine syrup is usually available as a dosage form of 5mg/5ml throughout the globe for the symptomatic relief of allergic reactions such as allergic rhinitis, urticaria in adults and children above 2 years of age. It is classified as a tricyclic antihistaminic drug which functions as a selective inverse agonist of the H1 receptors present in the peripheral cells. It is a second-generation antihistamine drug which is often formulated as a syrup either alone or in combination with other potent decongestant drugs.

The major segments related to the loratadine syrup market are:

By Indication (2017–2027; US$ Mn)

Allergic Rhinitis

Hives

Others

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment(2017–2027; US$ Mn)

North America

United States
Canada

Europe

United Kingdom
Germany
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

• The intention of the study is to give a comprehensive outlook of the global loratadine syrup market
• The overall segmentation of the loratadine syrup market, by indication, distribution channel, and geography is minutely studied. Allergic rhinitis and hospital pharmacy are dominating the indication and distribution channel segments respectively
• The constant rise in allergic reactions such as allergic rhinitis, urticaria, and other skin allergies primarily determines loratadine syrup market growth
• Exponential rise in the generic market in the developing nations propagates the loratadine syrup market growth

Report gist?

• The study of the global loratadine syrup market includes qualitative analysis of factors such as drivers, restraints, and opportunities
• The report covers qualitative and quantitative analysis of the overall market segmented on the basis of indication and distribution channel and categorization of the same at the geography level
• This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. Compounded annual growth rate is calculated for the respective segments from 2020 to 2027
• The study includes the profiles of major market players with a significant global and regional presence along with top company positioning

Significant customers?

• This study is suitable for industry participants and stakeholders in the pharmaceutical companies engaged in the manufacturing and marketing of loratadine syrup which is gaining huge demand owing to the rising prevalence of allergic reactions and flourishing generic drugs market worldwide
• The report will benefit pharmacist engaged in the compounding and sale of loratadine syrup for allergic reaction treatment
• Managers with financial institutions looking to publish recent and forecasted statistics pertaining to loratadine syrup market
• Financial institutions venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies

Segment Analysis

Allergic rhinitis is spearheading the indication segment for the loratadine syrup market. As per the statistics provided by the American Academy for Allergy, Asthma & Immunology (AAAAI), the sensitization of IgE antibodies towards foreign particles is prevalent in approximately 40% of the global population. Hives are gaining tremendous traction in the last 2 decades on account of a significant rise in water population and adverse drug reactions affecting almost 10% of the global population as per the report published in the World Health Organization (WHO) pharmacovigilance department.

Hospital pharmacy is dominating the distribution channel segment for the loratadine syrup market. The major contributing factor is the significant rise in the number of prescriptions mentioning loratadine for the treatment of allergic rhinitis in the developed regions. Retail pharmacy is gathering rapid momentum in its market growth owing to the presence of a well-developed generic drug market in the developing regions and availability of loratadine syrup as an over the counter product for the treatment of allergic reactions.

North America is currently representing the largest market share in the geography segment for Loratadine syrup market. The chief contributing factor for its market dominance is the rising prevalence of hay fever. As per the latest research citings provided by the Center for Disease Control and Prevention (CDC), approximately 19.2 million people are suffering from hay fever every year. Furthermore, the domicile of key manufacturers of Loratadine syrup such as Cardinal Health, NuCare Pharmaceuticals, Inc., Sandoz, Inc., etc further accentuates the market growth in the region. Europe is placed in the second position chiefly due to the rising prevalence of urticaria across all age groups. As per the latest information brought forward by the European Dermatology Forum (EDF), the prevalence rate of chronic urticaria in the European region is approximately 20%. The chief causative agents which cause urticaria in the region are intake of peanuts and uncooked raw meat and vegetables. The Asia Pacific is going to register comfortable market growth in the near future on account of the presence of developed generic drugs market and effective implementation of treatment guidelines pertaining to allergy and asthma resulting in an increased number of physicians prescription for loratadine syrup to relieve allergic symptoms.